Pro-Oxidant Therapeutic Activities of Cerium Oxide Nanoparticles in Colorectal Carcinoma Cells.
Journal
ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658
Informations de publication
Date de publication:
05 May 2020
05 May 2020
Historique:
received:
25
11
2019
accepted:
08
04
2020
entrez:
12
5
2020
pubmed:
12
5
2020
medline:
12
5
2020
Statut:
epublish
Résumé
Given that basal levels of reactive oxygen species (ROS) are higher in cancer cells, there is a growing school of thought that endorses pro-oxidants as potential chemotherapeutic agents. Intriguingly, cerium oxide (CeO
Identifiants
pubmed: 32391458
doi: 10.1021/acsomega.9b04006
pmc: PMC7203694
doi:
Types de publication
Journal Article
Langues
eng
Pagination
9714-9723Informations de copyright
Copyright © 2020 American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
Int J Mol Sci. 2013 Feb 01;14(2):3065-77
pubmed: 23377016
J Cell Physiol. 2012 Apr;227(4):1493-500
pubmed: 21678400
Cancer Res. 2007 Sep 15;67(18):8810-7
pubmed: 17875722
Biochem Soc Trans. 2008 Feb;36(Pt 1):1-9
pubmed: 18208375
Anal Chem. 2019 Jan 15;91(2):1408-1415
pubmed: 30457829
Integr Cancer Ther. 2018 Jun;17(2):210-216
pubmed: 28627256
Biomaterials. 2015 Aug;59:116-24
pubmed: 25968461
Chem Commun (Camb). 2007 Mar 14;(10):1056-8
pubmed: 17325804
Mol Oncol. 2020 Jan;14(1):69-86
pubmed: 31665549
Angew Chem Int Ed Engl. 2012 Oct 29;51(44):11039-43
pubmed: 22968916
Biomed Res Int. 2014;2014:891934
pubmed: 24987704
Nanomedicine (Lond). 2017 Jan;12(1):59-72
pubmed: 27876436
Phys Chem Chem Phys. 2019 Nov 28;21(44):24793-24801
pubmed: 31687703
Cell Death Dis. 2017 Jun 22;8(6):e2887
pubmed: 28640251
ACS Nano. 2011 Jun 28;5(6):4537-49
pubmed: 21612305
Trends Mol Med. 2017 May;23(5):411-429
pubmed: 28427863
J Clin Oncol. 2020 Mar 10;38(8):804-814
pubmed: 31855498
Sci Rep. 2018 Jan 25;8(1):1611
pubmed: 29371610
Cell Res. 2018 Aug;28(8):833-854
pubmed: 30030520
Methods Mol Biol. 2016;1473:17-22
pubmed: 27518619
Sci Rep. 2019 Jan 24;9(1):693
pubmed: 30679555
Cancers (Basel). 2018 Sep 01;10(9):
pubmed: 30200491
Nanomedicine. 2013 May;9(4):558-69
pubmed: 23178284
Chem Commun (Camb). 2010 Apr 28;46(16):2736-8
pubmed: 20369166
Cell Death Dis. 2018 Mar 6;9(3):365
pubmed: 29511177
Methods Mol Biol. 2012;920:613-26
pubmed: 22941631
Nanoscale. 2019 Mar 7;11(10):4552-4561
pubmed: 30806412
Angew Chem Int Ed Engl. 2018 May 14;57(20):5808-5812
pubmed: 29575461
FASEB J. 2020 Feb;34(2):3413-3428
pubmed: 31922321
J Cell Sci. 2009 Aug 15;122(Pt 16):2801-8
pubmed: 19795525
Cell Death Differ. 2006 Sep;13(9):1423-33
pubmed: 16676004
World J Gastrointest Oncol. 2014 Mar 15;6(3):55-66
pubmed: 24653795
Oncogene. 2004 Apr 12;23(16):2797-808
pubmed: 15077143
Nat Rev Mol Cell Biol. 2019 Mar;20(3):175-193
pubmed: 30655609
Int J Toxicol. 2006 Nov-Dec;25(6):451-7
pubmed: 17132603
Chem Commun (Camb). 2018 Dec 11;54(99):13973-13976
pubmed: 30480266
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015 May-Jun;7(3):315-29
pubmed: 25348382
Nat Rev Cancer. 2009 Jun;9(6):400-14
pubmed: 19440234